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INTRODUCTION
Autism spectrum disorder (ASD) remains a poorly understood disease despite major recent advances in identifying risk alleles and associated symptoms. Sequencing-based studies have identified over 800 risk alleles, highlighting the genetic complexity of ASD (Abrahams and Geschwind, 2008; Iossifov et al., 2012; O'Roak et al., 2011 O'Roak et al., , 2012a O'Roak et al., , 2012b Parikshak et al., 2013) . One approach to dissecting this complexity is to create mouse models that carry mutations that mirror those in patients (Nestler and Hyman, 2010; Silverman et al., 2010) , providing an entry point to studying the impact of risk alleles identified through genome sequencing.
One of the genes most strongly associated with ASD is chromodomain helicase DNA-binding protein 8 (CHD8), which encodes an ATP-dependent chromatin remodeler (Bernier et al., 2014; Iossifov et al., 2012; Neale et al., 2012; O'Roak et al., 2012a O'Roak et al., , 2012b Sanders et al., 2012; Talkowski et al., 2012; Zahir et al., 2007) . The first evidence for its role in ASD was the identification of disruptive CHD8 mutations in two unrelated children with cognitive impairment and developmental delay (Zahir et al., 2007) . Further investigation into balanced chromosomal abnormalities (Talkowski et al., 2012) and de novo exome sequencing of ASD patients suggested an important role for CHD8 in the brain (Iossifov et al., 2012; Neale et al., 2012; O'Roak et al., 2012a O'Roak et al., , 2012b Sanders et al., 2012) . Functional analysis using knockdown in human cells in vitro indicated that CHD8 regulates many ASD risk genes involved in neurodevelopment and synaptic function (Cotney et al., 2015; De Rubeis et al., 2014; Sugathan et al., 2014; Wilkinson et al., 2015) . Based on these lines of evidence, Bernier et al. (2014) performed targeted resequencing of 3,730 children with ASD or developmental delay and proposed a subtype of ASD patients with mutations in CHD8 and specific phenotypes.
To gain insight into the role of CHD8 in the brain, we generated mice carrying Chd8 heterozygous loss-of-function (LOF) mutations, the predominant form found in ASD patients. Chd8 +/-mice present with macrocephaly, craniofacial abnormalities, and behavioral deficits. Analysis of genome-wide CHD8 binding sites and brain-wide gene expression profiles shows brain regionspecific enrichments for other ASD-associated genes as well as histone and chromatin modification, mRNA processing, protein folding, and cell cycle. We find a nucleus accumbens (NAc)-specific upregulation in Wnt signaling, highlighting the importance of CHD8 regulation in this brain region. Based on this regulatory profile and the observed behavioral phenotypes, we investigated the electrophysiology of medium spiny neurons (MSNs) within the NAc and observed a decrease in local inhibitory signaling coinciding with an increase in spontaneous excitatory activity. Finally, in vivo perturbation of Chd8 in the NAc of wild-type adult animals recapitulates the acquired motor learning phenotype found in Chd8 +/-mice, linking striatal circuits to the observed phenotypes. These data provide insight into the role of CHD8 in the brain as well as its contribution to ASD.
RESULTS

Generation of a Chd8 LOF Mutant Mouse via Cas9-Mediated Germline Editing
To study the role of CHD8 expression in the brain, we generated germline mutant mice using Cas9 ( Figure 1A ). We designed three single guide RNAs (sgRNAs) targeting the Chd8 gene and tested their efficiency by transient transfection in mouse N2A cells followed by insertion and deletion (indel) analysis (Figures 1B and S1) . The optimal sgRNA was identified, co-injected with Cas9 mRNA into the pronucleus of C57BL/6 single cell zygotes, and implanted into recipient mothers at the two-cell stage (Wang et al., 2013) . Progeny were born with a variety of mutant alleles harboring indels at the target site ( Figure 1C ). Genotyping tail tissue revealed that individual animals had between one and four unique alleles, indicating that the first generation of gene edited progeny were mosaic. These animals likely resulted from unique editing events after division of the single cell zygote. To characterize the distribution of genotypes, animals were classified as having zero (wild-type, n = 27), one (monoallelic, n = 3), two (biallelic, n = 1), or more than two (multiallelic, n = 7) mutant allele(s) (Figures 1D and S1) . Mutations in CHD8 identified in patients are most often LOF, and therefore we reasoned that a Cas9-mediated indel causing a frameshift mutation within an early constitutive exon would be sufficient to disrupt protein expression. To establish a mouse line with a single, germline transmitted LOF mutation in Chd8, we crossed all of the first generation Chd8 mutant progeny (n = 11) to wild-type mice. Within each resulting litter at least one progeny harbored a mutant allele identified within the parent. We also identified new alleles not found in the tail snips of parents. Therefore, we refer to the first generation of germline edited progeny as ''mosaic founders'' to distinguish them from true founders with germline transmission of a single unique allele. One founder with germline transmission of a Chd8 allele containing a 7-nucleotide deletion in exon 1 that causes a frameshift mutation ( Figure 1C , bold sequence) was selected to establish the Chd8 +/-strain, which was used for all further analyses. Heterozygous mice showed approximately half the expression of CHD8 as compared to wild-type littermates ( Figure 1E ). As expected, homozygous mutant animals (Chd8 -/-) were not viable ( Figure 1F ) (Nishiyama et al., 2004 
CHD8 Is Expressed in Most Cell Types throughout the Brain
To understand the function of CHD8, we first determined the developmental expression profile of CHD8 protein in wild-type C57BL/6 mouse brain by performing western blots on whole brain samples collected throughout embryonic development (E11.5-E19.5) as well as in neonates (P0) and adults ( Figure S2B ). We found that CHD8 protein was expressed strongly during embryonic development, but also remains observable in neonates and adults (Figures S2B and S2C) . These results are consistent with results from human and macaque brains (Bernier et al., 2014) . To determine whether CHD8 expression was limited to a specific cell type, we prepared sections from adult (10-week-old males) Chd8 +/-mice and wild-type littermates. Immunofluorescence imaging shows that CHD8 expression is punctate and localized within the nucleus of almost every cell (CHD8-and DAPI-positive) ( Figures S2C-S2E ). Specifically, we find that CHD8 is expressed in mature neurons (NeuN-positive), interneurons (parvalbumin [PV]-positive), oligodendrocytes (CNP1-positive), and astrocytes (GFAP-positive) ( Figures S2D and S2E ). Interestingly, CHD8 is expressed in most, but not all DAPI-and NeuN-positive cells, suggesting a cellular population or a dynamic state in which CHD8 is not expressed.
CHD8 Affects Pathways Involved in Cell Cycle and
Histone and Chromatin Modification CHD8 is a chromatin modifier and transcription factor that has been shown to bind to $2,000 transcriptionally active genes in stable cell lines (Subtil-Rodríguez et al., 2014) . It therefore may regulate downstream genes associated with ASD risk. In support of this possibility, transcriptional profiling of human neural progenitor cells in which CHD8 was knocked down identified Figure S1 . (C) Sequences of Chd8 edited alleles in mosaic founders. Data represent all mutant alleles found within 38 animals from six recipient mothers. Bolded Chd8 allele with 7-nt deletion represents LOF mutation in established mouse line used for all phenotypic characterizations. (D) Classification and quantification of Chd8-targeted mosaic founder genotypes. Mice were classified as having zero (wild-type, n = 27), one (monoallelic, n = 3), two (biallelic, n = 1), or more than two (multiallelic, n = 7) mutant allele(s). See also Figure S1 . several dysregulated ASD-associated genes as well as other genes associated with synapse and brain development (Cotney et al., 2015; Sugathan et al., 2014; Wilkinson et al., 2015) . We investigated the genome-wide binding profile of CHD8 in the cortex of 10-week-old male mice to identify likely target genes as well as dysregulated pathways. As a control both chromatin immunoprecipitation sequencing (ChIP-seq) inputs and IgG conditions on age and genotype tissue were utilized. Peaks were called for each genotype-control pair using MACS2 (false discovery rate [FDR] cutoff of 1%) and only peaks shared between input and IgG conditions were considered. We found that CHD8 binding sites are enriched in promoters (38% of all CHD8 peaks) ( Figure 2A ) with peaks centered on the transcriptional start site (TSS) ( Figure 2B Figure 1I ) along with alterations in cell cycle and the dysregulation of master regulators of cortical development led us to test whether a reduction in CHD8 disrupts lamination and specification of cortical neuron subtypes. We investigated morphology and major cell types within the cortex by examining immunostained brain sections collected from 21-day-old male mice. Morphological analysis using Nissl staining shows no overt phenotype present in the somatosensory cortex of Chd8 +/-mice compared to wild-type littermates ( Figures S3A and S3B ). Upon immunostaining for Cux1, a marker for layer II/III/IV projection neurons, and Bcl11b, a marker for layer V/VI projection neurons, we observed no significant differences between Chd8 +/-mice and wild-type littermates within the somatosensory cortex ( Figure S3B ). Similarly, immunostaining for parvalbumin (PV)-positive interneurons and Olig2-positive oligodendrocytes showed no overt differences within the somatosensory cortex of Chd8 +/-mice compared to wild-type littermates ( Figure S3B ). We next tested whether a reduction in CHD8 resulted in defects within the cortical progenitor population. In particular, we examined both the number of cortical progenitors as well as the cell-cycle length in embryonic day 15.5 (E15.5) embryos. We performed intraperitoneal injections of 5-bromo-2 0 -deoxyuridine (BrdU) and 5-ethynyl-2 0 -deoxyuridine (EdU) in pregnant dams 120 and 30 min prior to euthanasia ( Figure S3C ) (MairetCoello et al., 2012; Watanabe et al., 2015 Figure S3D ). Finally, we examined whether CHD8 was altering the cell-cycle length, as would be predicted from previous studies as well as enrichment for cell-cycle regulation genes enriched in CHD8 peaks. However, examination of brain sections showed no increase in either the total cell-cycle length (wild-type [n = 6] 9.4 ± 0.5 hr SEM, Chd8 +/-[n = 6] 10.3 ± 0.1 hr SEM, two-tailed t test p value = 0.107) ( Figure S3E ) or the length of S phase (wild-type [n = 6] 2.8 ± 0.1 hr SEM, Chd8
[n = 6] 3.0 ± 0.3 hr SEM, two-tailed t test p value = 0.430) (Figure S3F) within the somatosensory cortex of Chd8 +/-mice compared to wild-type littermates. Taken together, these data suggest that reduction in CHD8 in mice results in no gross defects in specification, migration, or lamination of different subtypes in the neocortex.
Chd8
+/-Mice Exhibit Broad Gene Expression Changes throughout the Brain Considering CHD8 is not only expressed in cortex but throughout the brain in most cell types, we set out to characterize the brain-wide transcriptional changes resulting in a decrease of CHD8 in an unbiased way. We performed RNA sequencing on microdissected tissue from 10-week-old males. We investigated brain regions previously implicated in ASD, namely the medial prefrontal cortex (mPFC), dorsal striatum (DS), NAc, ventral tegmental area (VTA), hippocampal formation (HPF), amygdala (AM), and lateral hypothalamus (LH).
We performed differential expression analysis within each region and found brain region-specific dysregulation in Chd8 +/-mice compared to wild-type littermates ( Figure S4A ). The top ten up-and downregulated genes irrespective of brain region are shown ( Figure 3A ). Dysregulated genes found within more than one region are Eif2b5 (DS and AM), Nbl1 (NAc and LH), and Mgp (HPF and AM). Select differentially expressed genes within the NAc were validated by RT-qPCR ( Figure S4B ). Among the differentially expressed genes, we find genes previously associated with ASD, some of which are well-characterized causal mutations while others are uncharacterized ( Figure 3B ). In particular, we find transcription factors essential for the development of the brain (i.e., FoxG1), global regulators of the epigenome (i.e., Mecp2 and Tet2), as well as many neuronal and synaptic adhesion molecules, such as Kank1, Cntnap5b, Cntn6, Ankrd11, Pcdh15, Pcdha8, and Pcdha9. Many of these genes are also directly bound by CHD8 ( Figure 3B ). To identify entire pathways dysregulated in Chd8 +/-mice, we performed gene set enrichment analysis (GSEA) ( Figure 3C ). Consistent with previous reports that CHD8 acts as a negative regulator of Wnt signaling, we identified a NAc-specific positive enrichment for Wnt signaling.
Chd8 +/-Mice Exhibit Synaptic Dysfunction within MSNs in the NAc
The observations that Wnt signaling and synaptic adhesion molecules are dysregulated in the NAc prompted us to further characterize the role of CHD8 in this region. To study whether mutation of Chd8 results in altered synaptic transmission, we assayed several electrophysiological parameters of MSNs in the core region of the NAc by whole cell slice recording utilizing aged-matched littermates between 6-8 weeks old. Figure 4C ). To further investigate whether cortical inputs and presynaptic components contribute to the increased excitatory inputs onto MSNs in the NAc, we examined the paired pulse ratio (PPR) between EPSCs using parasagittal slice preparation as demonstrated previously (Rothwell et al., 2014 Figure 4D ). These results suggest that a local decrease of inhibitory transmission may contribute to the enhanced excitatory inputs onto MSNs in the NAc in Chd8 +/-mice. type littermate pairs at postnatal days 23-25 as previously described (Bolivar et al., 2007; McFarlane et al., 2008; Yang et al., 2009 ( Figure S5A) (Figure S5D) , nose-to-nose duration (wild-type [n = 15] 10.8 ± 0.9 s SEM, Chd8 Figure S5H ). We then performed the three-chambered social approach task with age-matched Chd8 +/-mice and wild-type. As previously described, the three-chambered assay involves habituation, a sociability test, and a social novelty (Chadman et al., 2008; Chao et al., 2010; McFarlane et al., 2008; Moy et al., 2004; Silverman et al., 2010; Yang et al., 2009) . No preference for either side of the test apparatus was observed for mice in either group during the habituation phase ( Figures S5I and  S5J ). In the sociability test of the three-chambered assay, we counterbalanced the object and social sides for each experimental mouse, and experimental mice were given free access to interact with a novel mouse or a novel object. During this phase, both Chd8 +/-mice and wild-type littermates displayed significant preference for the novel mouse compared to the novel object (wild-type [n = 20] 160 ± 10 [novel object chamber] 80 ± 6 [middle chamber] 330 ± 20 [novel mouse chamber] 84 ± 8 [novel object direct interaction] 180 ± 10 [novel mouse direct interaction] s SEM). The statistical test used was a one-way ANOVA with Bonferroni post hoc test: novel object versus novel mouse chamber p value < 0.001, novel object versus novel mouse direct interaction p value < 0.001; Chd8 +/-(n = 24) 140 ± 9 (novel object chamber) 80 ± 10 (middle chamber) 340 ± 20 (novel mouse chamber) 82 ± 6 (novel object direct interaction) 220 ± 10 (novel mouse direct interaction) s SEM. The statistical test used was a one-way ANOVA with Bonferroni post hoc test: novel object versus novel mouse chamber p value < 0.001, novel object versus novel mouse direct interaction p value < 0.001] (Figure 5C ). In the social novelty test phase, experimental mice were given free access to interact with a novel mouse or a familiar mouse. In this phase, wild-type littermates but not Chd8 +/-mice, displayed significant preference for the novel mouse compared to the familiar mouse [wild-type (n = 20) 220 ± 20 (familiar mouse chamber) 100 ± 10 (middle chamber) 240 ± 20 (novel mouse chamber) 90 ± 10 (familiar mouse direct interaction) 130 ± 20 (novel mouse direct interaction) Figure 5E ). Moreover, no skin lesions were found on any Chd8 +/-mouse or wild-type littermate for the duration of our study. In the marble burying assay, which takes place in a novel testing cage with 24 marbles introduced, we did not observe a difference in the number of marbles buried between genotypes (wild-type [n = 23] 12.6 ± 0.8 marbles SEM, Chd8
[n = 25] 10 ± 1 marbles SEM, two-tailed t test p value = 0.125) ( Figure 5F ). Together, these results suggest that Chd8 +/-mice do not display repetitive grooming or burying behaviors.
To assess the memory performance of Chd8 +/-mice, we conducted a memory test by subjecting mice to either a contextual or toned fear conditioning task. During the training phase, Chd8 +/-mice exhibited a similar percentage of freezing behavior compared to wild-type littermates (repeated-measures two-way ANOVA with Bonferroni post hoc test, adjusted p value > 0.05 for each time point) ( Figure S6A ). Percentages of freezing time per 30-s bin across the training were compared, and no difference was detected between genotypes. After being conditioned to aversive electrical shocks, mice were placed into the test apparatus with identical context 24 hr later. During the contextual fear conditioning, we observed no difference in freezing time between genotypes (wild-type [n = 16] 34% ± 3% SEM, Chd8 +/-(n = 21) 35% ± 3% SEM, two-tailed t test p value = 0.788) ( Figure S6B ). Similarly, during the tone fear conditioning, we observed no difference in freezing time between genotypes (wild-type [n = 16] 31% ± 2% SEM, Chd8 +/-(n = 21) 34% ± 2% SEM, two-tailed t test p value = 0.231) ( Figure S6C ). We did observe a significant difference in freezing time between the baseline and tone conditions for both genotypes (wild-type [n = 16] baseline 6% ± 1% SEM, tone 30% ± 2% SEM, two-tailed t test p value < 0.001, Chd8 +/-[n = 21] baseline 4.9% ± 0.9% SEM, tone 34% ± 2% SEM, two-tailed t test p value < 0.001) ( Figure S6C ). These data suggest that both contextual fear conditioning and tone-based fear conditioning are intact in Chd8 +/-mice.
Many individuals with ASD experience various degrees of anxiety, including a population of ASD patients with CHD8 mutations (Bernier et al., 2014; Merner et al., 2016; White et al., 2009) . Increased anxiety-like behaviors were also frequently detected in many mouse models of ASD (Kazdoba et al., 2014; McGill et al., 2006; Zhou et al., 2016 (Rothwell et al., 2014) among others (Etherton et al., 2009; Nakatani et al., 2009; Peñ agarikano et al., 2011) . Interestingly, MSN-and NAc-specific mutation of NLGN3 (R451C or LOF) results in an increase in acquired motor learning in the rotarod performance test (Rothwell et al., 2014) .
To test whether CHD8 expression in the NAc of adults was required for the acquired motor learning phenotype, we first validated that Chd8 was expressed in the NAc of adult animals ( Figure S7A ). We then stereotactically injected adeno-associated virus (AAV) vectors containing Chd8-targeting sgRNA (Figures 7A-7B ) into either the NAc or the dorsal striatum of Cas9 knockin mice (Platt et al., 2014) (Figure 7C ). Control mice were injected with an AAV carrying a non-targeting sgRNA (sgLacZ) into the NAc. Six weeks after injection, we performed immunohistochemistry ( Figure 7D ), microdissected the injected region, and genotyped individual fluorescence-activated cell sorting (FACS) EGFP-KASH-tagged fluorescent nuclei by Illumina sequencing. AAV-mediated delivery of Chd8-targeting sgRNA mediated robust mutagenesis of the Chd8 allele. We observed cells with zero (wild-type, 10%), one (monoallelic, 57%), or two (biallelic, 33%) mutant alleles ( Figure 7E ). We then performed the rotarod performance test on injected animals and found that perturbation of Chd8 in the NAc (sgChd8-NAc) but not the dorsal striatum (sgChd8-DS) improved acquired motor learning in the rotarod performance test compared to control injected animals (sgLacZ-NAc) (sgChd8-NAc versus sgLacZ-NAc: Figure 7F ). By contrast, in the open field test, we observed no differences between genotypes (Figures S7B and S7C ). Taken together, these results demonstrate that CHD8 expression in adults is not required for the increased anxiety-like or decreased locomotor behavior but is required for acquired motor learning in the rotarod performance test.
DISCUSSION
Our findings demonstrate an important role for CHD8 in neurodevelopment, physiology, and behavior. We showed that Chd8 +/-mice exhibit a reduction in CHD8 expression, macrocephaly and craniofacial abnormalities, and altered behavior, including anxiety-like behavior, a mild social behavior defect, and increased acquired motor learning, but we did not observe a change in repetitive behavior. Together, we find that Chd8 +/-mice display some but not all of the phenotypic outcomes relevant to the diagnostic symptoms found in human patients.
ChIP-seq and RNA sequencing (RNA-seq) revealed a broad role for CHD8 in genome regulation, including control of cell cycle, histone and chromatin modifications, and mRNA and protein processing. These observations were brain region-specific, suggesting differential effects across cells and circuits in the developing and adult brain. We find alterations in expected pathways based on previous studies (i.e., Wnt and p53 signaling) as well as novel effectors connecting chromatin modification (i.e., Hdac4 and Chd7) and histone methylation (i.e., Mecp2 . These data provide support that CHD8 influences the expression of many genes and pathways some of which likely result in the observed neuropathology. CHD8 LOF mutations are strongly associated with ASD, and evidence suggesting that CHD8 plays a causal role in neurodevelopment and ASD neuropathology is mounting (Bernier et al., 2014; Iossifov et al., 2014; O'Roak et al., 2012a O'Roak et al., , 2012b . Early insights into the function of CHD8 revealed a modulatory role in Wnt signaling, which may lead to altered neurogenesis and cortical development. We confirmed that CHD8 is a negative regulator of Wnt signaling. In keeping with this, we observed morphological phenotypes, namely macrocephaly and craniofacial abnormalities, but not an overt phenotype in the major cortical cell types, lamination of the cortex, or number and cellcycle length of mid-stage cortical progenitors. These findings suggest that cell-type specification and radial lamination of the cortex, which are mid-to late-stage cortical developmental processes, are largely intact in Chd8 +/-mice.
Chd8 mutation results in striatal dysfunction and an increased acquired motor learning behavioral phenotype mediated by synaptic transmission within MSNs in the NAc. These findings combined with previous reports implicating the striatum (Di Martino et al., 2011; Hollander et al., 2005; Peç a et al., 2011) and in particular the NAc (Dö len et al., 2013; Grueter et al., 2013; Gunaydin et al., 2014; Rothwell et al., 2014) , strongly suggest the NAc is an important node for social behavior and ASD pathology. Circuit mapping studies will be valuable for further understanding the links between MSNs in the NAc, striatal circuits, and ASD risk alleles in the context of ASD pathology.
Increased acquired motor learning has been reported for other mouse models of ASD (Michalon et al., 2012; Osterweil et al., 2013; Rothwell et al., 2014; Tian et al., 2015) . For example, Rothwell et al. (2014) directly mapped the role of NLGN3 and NLGN3 [R451C] in MSNs of the NAc to acquired motor learning. While we observed increased acquired motor learning by rotarod in Chd8 +/-mice, it did not definitively implicate CHD8 expression in the NAc of adult mice. Therefore, we utilized CRISPR-Cas9 knockin mice to perturb Chd8 directly in vivo to map the relationship. In NAc-specific Chd8 perturbed mice, we were able to recapitulate the acquired motor learning phenotype observed in germline mutant animals. Together, these data demonstrate a functional role of CHD8 in the adult brain in the NAc, which we directly link to behavioral phenotypes. Recently, two independent groups reported the characterization of Chd8 loss-of-function mutations in mice (Durak et al., 2016; Katayama et al., 2016) . These additional studies confirm that Chd8 +/-mice show abnormal social and anxiety-like behavior as well as a macrocephaly phenotype, but no unifying mechanism for CHD8 function has emerged from those works. Together with these previous reports, our findings support the hypothesis that CHD8 acts by globally regulating many genes, highlighting several specific pathways that may be linked to animal behaviors relevant to ASD pathology. These studies provide a first look at the molecular and physiological consequences of LOF mutations in CHD8 on the developing and adult brain, elucidating critical defects as well as providing mechanistic insights. Our demonstration that Chd8 +/-mice display hallmark features similar to those found in some ASD patients and characterization of the circuits underlying these behaviors open up broad avenues for future work. These results causally implicate CHD8 in ASD pathogenesis and provide a link between chromatin modification affecting the synapse and broader circuits connecting through the nucleus accumbens.
EXPERIMENTAL PROCEDURES
Germline Editing of Chd8 with Cas9 sgRNAs were designed using the CRISPRtool (http://crispr.mit.edu/) and tested by SURVEYOR assay (Transgenomic) according to the manufacturer's protocol. The sequences of which are listed in Table S1 along with genomic primers. Human codon optimized Cas9 (from Streptococcus pyogenes) capped and polyadenylated mRNA and sgRNA RNA were co-injected by pronuclear injection at concentration of 200 ng/mL Cas9 mRNA and 50 ng/mL and 200 ng/mL, respectively.
Immunofluorescence on Adult Brain
Adult male mice were transcardially perfused and brains were sectioned at 40 mm on a vibrating microtome and stained as previously described (Platt et al., 2014) . Primary antibodies and dilutions used were as follows: anti-CHD8 (1:1,000, Cell Signaling Technology, P58438), anti-NeuN (1:800, Cell Signaling Technology, 12943), anti-GFP (1:1,600, Nacalai Tesque, GF090R), anti-parvalbumin (1:1,000, Sigma Aldrich, P3088), anti-GFAP (1:1,000, Aves Labs, GFAP), anti-S100b (1:1,000, Abcam, ab4066), and anti-CNP1 (1:1,000, Synaptic Systems, 255004). Secondary antibodies and dilutions used were as follows: AlexaFluor 405, 488, 568, and/or 647 secondary antibody (1:400, Life Technologies).
Immunofluorescence on Embryonic and Juvenile Brain E15.5 embryos were dissected and fixed in 4% paraformaldehyde (PFA) overnight. P21 pups were transcardially perfused with PBS, then with 4% PFA, dissected, and postfixed in 4% PFA overnight. Brains were sectioned at 40 mm on a vibrating microtome (Leica VT1000S) and stained as previously described (Lodato et al., 2014) . Primary antibodies and dilutions used were as follows: rat anti-CTIP2 antibody (1:100, Abcam ab18465), mouse anti-SATB2 (1:50, Abcam ab51502), mouse anti-Pvalb (1:1,000, Millipore MAB), rabbit anti Olig2 (IBL-18953), mouse anti BrdU (Millipore MAB), rabbit anti Ki67(Abcam ab15580), and rabbit anti-CUX1 (1:100, Santa Cruz CDP M-222). Secondary antibodies and dilutions used were as follows: AlexaFluor 405, 488, 568, and/or 647 secondary antibody (1:750, Life Technologies).
Quantification of BrdU Incorporation and Cell-Cycle Length
To estimate the cell-cycle length, we conducted a dual-pulse-labeling of DNA synthesis using 5-bromo-2 0 -deoxyuridine (BrdU; Sigma-Aldrich) and 5-ethynyl-2 0 -deoxyuridine (EdU; Molecular Probes) as previously described (MairetCoello et al., 2012; Watanabe et al., 2015) . Timed pregnant C57BL/6 females, crossed with Chd8 +/-males, received one intraperitoneal injection of BrdU (50 mg/kg) and EdU (12.5 mg/kg) 120 and 30 min before sacrifice, respectively, and the ratios of cells that incorporated either or both BrdU and EdU were analyzed to estimate the cell-cycle length. The detection of EdU-labeled cells was performed based on a fluorogenic click reaction (Salic and Mitchison, 2008) . For detection of BrdU, antigen retrieval was done by incubating sections in 2 N HCL for 20 min. For counting and colocalization analyses of BrdU, EdU, and Ki67, confocal images of a 300 mm square ROI spanning the entire ventricular zone was imaged using Zeiss LSM 700 and analyzed by an independent investigator who was blinded to genotype and experimental conditions. At least 1,000 cells were counted per section, three to four mid-cortex sections per genotype were counted. For cell-cycle estimation was performed as previously described (Mairet-Coello et al., 2012; Watanabe et al., 2015) . Briefly, all Ki67 cells present in the region of interest (ROI) were counted and the existence of co-staining with BrdU and/or EdU was noted. For BrdU incorporation, all BrdU-positive cells present in the ROI were counted.
ChIP-Seq
ChIP was performed as previously described (Hathaway et al., 2012) . Somatosensory cortices were dissected from 10-to 11-week-old adult males and homogenized. Tissues were fixed in 1% formaldehyde for 10 min at 25 C and then quenched in 0.125 M glycine on ice. Cross-linked cells were sonicated to produce chromatin fragments of 200-700 bp in length. Chromatin fragments were then incubated overnight at 4 C with anti-CHD8 antibody (Novus Biologicals, NB100-60417). DNA was extracted with phenol chloroform, followed by ethanol precipitation. ChIP-seq libraries were prepared according to the NEBNext protocol and sequenced using Illumina NextSeq. The reads were uniquely mapped to the mm10 genome utilizing Bowtie2 version 2.2.1(Langmead and Salzberg, 2012) and duplicated reads were removed with Samtools version 1.3 (Li et al., 2009 ) peaks were called using MACS2 version 2.1.1 (Zhang et al., 2008) with FDR cutoff of 5%. Binding site annotation and distance to TSS was performed using HOMER version 4.8 (Heinz et al., 2010) . Functional enrichment and ontology was performed using GREAT version 3.0.0 (McLean et al., 2010) .
RNA Sequencing
Relevant brain regions were microdissected from 10-to 12-week-old male mice and rapidly frozen on dry ice. RNA was purified by RNAeasy Plus Micro Kit (QIAGEN) according to the manufacturer's protocol. mRNA sequencing libraries were prepared using SMART-Seq2 (Picelli et al., 2013) and sequenced on the NextSeq system (Illumina). Transcripts were mapped and quantified using RSEM (Li and Dewey, 2011) . Using a log2 transcripts per million expression matrix, differential expression analysis was performed using DEseq2 (Love et al., 2014) and nominal p values are reported. Gene set enrichment analysis was performed using GenePattern (open source from the Broad Institute). Sample distances and hierarchical clustering were performed using GENE-E (open source from the Broad Institute) using average linkages and Pearson's correlation. Heatmaps were also created using GENE-E using mean subtracted and SD row normalized values.
Western Blot
Protein lysates were prepared, quantified, and equally loaded on 4%-20% Tris-HCL Criterion Gel (Bio-Rad). Proteins were transferred onto PVDF membrane (Bio-Rad), blocked, and stained overnight using the following primary antibodies: anti-CHD8 (1:1,000, Bethyl, A301-2214A), HRP conjugated anti-GAPDH (1:5,000, Cell Signaling Technology, 3683), and HRP-conjugated anti-ACTB (1:1,000, Cell Signaling Technologies, 5125). Membranes were washed and stained with secondary antibodies: HRP-conjugated secondary antibodies (1:10,000, Cell Signaling Technology, 7074 and 7076). Membranes were washed, developed using SuperSignal West Femto Substrate (Pierce), and imaged on a gel imager (Bio-Rad).
Mouse Behavior
For all behavioral experiments, unless otherwise noted, we used 10-to 14-week-old group housed males weaned in groups with littermates of similar genotype. In all behavior experiments animals were randomized and experimenters were blinded to animal genotype during behavioral tests and data analysis. See the Supplemental Information for detailed description of each behavioral test.
Patch Clamp Slice Electrophysiology
Slice preparation, data acquisition, and analysis were performed with experimenter blinded to mice genotype as described in previous reports (Peç a et al., 2011; Rothwell et al., 2014; Zhou et al., 2016) . See the Supplemental Information for detailed description of each measurement.
RNA-FISH C57BL/6J male mice (Jackson Laboratories) adult (>6 weeks old) and day 17 (E17) embryonic brains were dissected and placed directly into either 10% neutral buffered formalin (NBF) or 4% paraformaldehyde (PFA) + 0.5% acetic acid and fixed for 1, 3, or 12 hr. After fixation, brains were embedded in paraffin and sliced at 5-mm thickness and mounted on glass slides without coverslips. These slides were processed using QuantiGene ViewRNA ISH Tissue (Affymetrix). FISH probes targeting the 5 th to the 12 th exon of Chd8 transcripts were ordered from Affymetrix. Slides were processed according to the Quantigene ViewRNA ISH protocol. Slides were imaged on a Zeiss Axio microscope under 203 or 403 objectives and fluorescent images were taken using a Cy3/TRITC filter for Fast Red and a DAPI filter for DAPI.
AAV1/2 Production AAV1/2 was produced as previously described (McClure et al., 2011; Platt et al., 2014) . Briefly, low passage HEK293FT cells (Life Technologies) were transfected with the plasmid of interest, pAAV1 plasmid, pAAV2 plasmid, helper plasmid pDF6, and PEI Max (Polysciences, 24765-2). AAV particles were purified using HiTrap heparin columns (GE Biosciences 17-0406-01).
Stereotactic Injection
Stereotactic injection was performed as previously described (Platt et al., 2014) . Briefly, anesthetized male mice at least 6 weeks of age were injected with 1.25 mL of AAV virus bilaterally in the nucleus accumbens (AP +1.50, ML ±1.10, DV -4.40) or the dorsal striatum (AP +0.70, ML ±2.50, DV -2.40) at 100 nL/min. After injection, the needle was left in place for 5 min before slowly being retracted.
Single Nuclei Preparation by FACS
Single nuclei experiments were performed as previously described (Platt et al., 2014) . Briefly, 6 weeks post-injection, the infected (EGFP + ) regions were dissected, flash frozen on dry ice, and stored at -80 C until use. The tissue was gently homogenized in nuclei were isolated followed by gradient centrifugation. Nuclei labeled with Vybrant DyeCycle Ruby Stain (Life Technologies) and sorted using a BD FACSAria III. EGFP + nuclei were sorted into individual wells of a 96-well plate and used as an input for single-cell indel analysis. 
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